Progesterone Improves Outcomes in Severe Traumatic Brain Injury
Author Information
Author(s): Xiao Guomin, Wei Jing, Yan Weiqi, Wang Weimin, Lu Zhenhui
Primary Institution: Hangzhou Normal University
Hypothesis
Does the administration of progesterone improve neurologic outcomes in patients with acute severe traumatic brain injury?
Conclusion
Patients with acute severe TBI who received progesterone showed improved neurologic outcomes for up to 6 months compared to those who received a placebo.
Supporting Evidence
- Patients receiving progesterone had a higher percentage of favorable outcomes at both 3 and 6 months.
- The mortality rate was significantly lower in the progesterone group at 6 months.
- Progesterone treatment resulted in higher modified Functional Independence Measure scores compared to placebo.
Takeaway
Giving progesterone to people with serious brain injuries can help them get better over time.
Methodology
A randomized, placebo-controlled trial involving 159 patients with severe TBI, comparing outcomes after treatment with progesterone versus placebo.
Potential Biases
Potential bias due to the single-center design and the inability to obtain informed consent from some patients.
Limitations
The study was conducted at a single center, which may limit the generalizability of the results.
Participant Demographics
Patients aged 18 to 65 years with a Glasgow Coma Scale score ≤ 8.
Statistical Information
P-Value
0.034
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website